Interleukin 17 in vascular inflammation

Cytokine and Growth Factor Reviews

Volumn 21, Issue 6, 2010, Pages 463-469

  von Vietinghoff, Sibylle ^a,b   Ley, Klaus ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Atherosclerosis; Interleukin 17; T cells; Vasculitis; Vasculopathy

Indexed keywords

APOLIPOPROTEIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; RECOMBINASE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR FOXP3; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE CORONARY SYNDROME; ADAPTIVE IMMUNITY; ARTICLE; ATHEROSCLEROSIS; B LYMPHOCYTE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; ENDOTHELIUM CELL; GIANT CELL ARTERITIS; HUMAN; HYPERTENSION; INNATE IMMUNITY; LEUKOCYTE; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MAST CELL; MONOCYTE; NEUTROPHIL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VASCULITIS;

ACUTE CORONARY SYNDROME; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; AUTOIMMUNE DISEASES; HUMANS; HYPERTENSION; INTERLEUKIN-17; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; VASCULITIS;

EID: 78649718588     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2010.10.003     Document Type: Article

References (84)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367(9524):1747-1757.
2. Jennette J.C., Falk R.J. Nosology of primary vasculitis. Curr Opin Rheumatol 2007, 19(1):10-16.
3. Mitchell R.N. Graft vascular disease: immune response meets the vessel wall. Annu Rev Pathol 2009, 4:19-47.
4. Wick G., Romen M., Amberger A., Metzler B., Mayr M., Falkensammer G., et al. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J 1997, 11(13):1199-1207.
5. Jongstra-Bilen J., Haidari M., Zhu S.N., Chen M., Guha D., Cybulsky M.I. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J Exp Med 2006, 203(9):2073-2083.
6. Galkina E., Kadl A., Sanders J., Varughese D., Sarembock I.J., Ley K. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially l-selectin dependent. J Exp Med 2006, 203(5):1273-1282.
7. Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008, 8(10):802-815.
8. Zhu S.N., Chen M., Jongstra-Bilen J., Cybulsky M.I. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J Exp Med 2009, 206(10):2141-2149.
9. Rekhter M.D., Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol 1995, 147(3):668-677.
10. Feihl F., Liaudet L., Levy B.I., Waeber B. Hypertension and microvascular remodelling. Cardiovasc Res 2008, 78(2):274-285.
11. Rekhter M., Nicholls S., Ferguson M., Gordon D. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb 1993, 13(4):609-617.
12. Pickering J.G., Weir L., Jekanowski J., Kearney M.A., Isner J.M. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest 1993, 91(4):1469-1480.
13. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006, 6(7):508-519.
14. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G.K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986, 6(2):131-138.
15. Hansson G.K., Seifert P.S., Olsson G., Bondjers G. Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler Thromb 1991, 11(3):745-750.
16. Kleindienst R., Xu Q., Willeit J., Waldenberger F.R., Weimann S., Wick G. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol 1993, 142(6):1927-1937.
17. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of T (H)17 cells. Nature 2008, 453(7198):1051-1057.
18. Iwakura Y., Nakae S., Saijo S., Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 2008, 226:57-79.
19. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007, 8(6):639-646.
20. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8(9):950-957.
21. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010;129(3):311-21.
22. Libby P., Ridker P.M., Hansson G.K. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009, 54(23):2129-2138.
23. Mallat Z., Taleb S., Ait-Oufella H., Tedgui A. The role of adaptive T cell immunity in atherosclerosis. J Lipid Res 2009, 50(Suppl.):S364-S369.
24. Dansky H.M., Charlton S.A., Harper M.M., Smith J.D. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 1997, 94(9):4642-4646.
25. Gotsman I., Sharpe A.H., Lichtman A.H. T-cell costimulation and coinhibition in atherosclerosis. Circ Res 2008, 103(11):1220-1231.
26. Zhou X., Nicoletti A., Elhage R., Hansson G.K. Transfer of CD4 (+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000, 102(24):2919-2922.
27. Elhage R., Gourdy P., Brouchet L., Jawien J., Fouque M.J., Fievet C., et al. Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am J Pathol 2004, 165(6):2013-2018.
28. Buono C., Binder C.J., Stavrakis G., Witztum J.L., Glimcher L.H., Lichtman A.H. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc Natl Acad Sci USA 2005, 102(5):1596-1601.
29. Buono C., Come C.E., Stavrakis G., Maguire G.F., Connelly P.W., Lichtman A.H. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol 2003, 23(3):454-460.
30. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997, 99(11):2752-2761.
31. -/- mice. Am J Pathol 2000, 157(6):1819-1824.
32. Tellides G., Tereb D.A., Kirkiles-Smith N.C., Kim R.W., Wilson J.H., Schechner J.S., et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000, 403(6766):207-211.
33. Ait-Oufella H., Salomon B.L., Potteaux S., Robertson A.K., Gourdy P., Zoll J., et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006, 12(2):178-180.
34. Gotsman I., Gupta R., Lichtman A.H. The influence of the regulatory T lymphocytes on atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27(12):2493-2495.
35. Sasaki N., Yamashita T., Takeda M., Shinohara M., Nakajima K., Tawa H., et al. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation 2009, 120(20):1996-2005.
36. Eid R.E., Rao D.A., Zhou J., Lo S.F., Ranjbaran H., Gallo A., et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009, 119(10):1424-1432.
37. Taleb S., Romain M., Ramkhelawon B., Uyttenhove C., Pasterkamp G., Herbin O., et al. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 2009, 206(10):2067-2077.
38. Smith E, Prasad KM, Butcher M, Dobrian A, Kolls JK, Ley K, et al. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation.
39. van Es T., van Puijvelde G.H., Ramos O.H., Segers F.M., Joosten L.A., van den Berg W.B., et al. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun 2009, 388(2):261-265.
40. Erbel C., Chen L., Bea F., Wangler S., Celik S., Lasitschka F., et al. Inhibition of IL-17A attenuates atherosclerotic lesion development in ApoE-deficient mice. J Immunol 2009, 183(12):8167-8175.
41. Shimizu K., Mitchell R.N., Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006, 26(5):987-994.
42. Yuan X., Paez-Cortez J., Schmitt-Knosalla I., D'Addio F., Mfarrej B., Donnarumma M., et al. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008, 205(13):3133-3144.
43. Liang J., Zheng Z., Wang M., Han L., Peng J., Liu Z., et al. Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes. J Int Med Res 2009, 37(3):862-866.
44. Ma D., Zhu X., Zhao P., Zhao C., Li X., Zhu Y., et al. Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura. Ann Hematol 2008, 87(11):899-904.
45. Guzik T.J., Hoch N.E., Brown K.A., McCann L.A., Rahman A., Dikalov S., et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007, 204(10):2449-2460.
46. Harrison DG, Vinh A, Lob H, Madhur MS. Role of the adaptive immune system in hypertension. Curr Opin Pharmacol 2010;10(2):203-7.
47. Kvakan H., Luft F.C., Muller D.N. Role of the immune system in hypertensive target organ damage. Trends Cardiovasc Med 2009, 19(7):242-246.
48. Madhur M.S., Lob H.E., McCann L.A., Iwakura Y., Blinder Y., Guzik T.J., et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010, 55(2):500-507.
49. Platten M., Youssef S., Hur E.M., Ho P.P., Han M.H., Lanz T.V., et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci USA 2009, 106(35):14948-14953.
50. Herrada A.A., Contreras F.J., Marini N.P., Amador C.A., Gonzalez P.A., Cortés C.M., et al. Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. J Immunol 2010, 184(1):191-202.
51. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37(2):187-192.
52. Weyand C.M., Goronzy J.J. Medium- and large-vessel vasculitis. N Engl J Med 2003, 349(2):160-169.
53. Deng J, Younge BR, Olshen RA, Goronzy JJ, Weyand CM. Th17 and Th1 T-cell responses in giant cell arteritis. Circulation 2010;121(7):906-15.
54. Sohn M.H., Noh S.Y., Chang W., Shin K.M., Kim D.S. Circulating interleukin 17 is increased in the acute stage of Kawasaki disease. Scand J Rheumatol 2003, 32(6):364-366.
55. Nogueira E, Hamour S, Sawant D, Henderson S, Mansfield N, Chavele KM, et al. Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant.
56. Abdulahad W.H., Stegeman C.A., Limburg P.C., Kallenberg C.G. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2008, 58(7):2196-2205.
57. Saito H., Tsurikisawa N., Tsuburai T., Oshikata C., Akiyama K. Cytokine production profile of CD4+ T cells from patients with active Churg-Strauss syndrome tends toward Th17. Int Arch Allergy Immunol 2009, 149(Suppl. 1):61-65.
58. Garrett-Sinha L.A., John S., Gaffen S.L. IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol 2008, 20(5):519-525.
59. Crispin JC, Tsokos GC. Interleukin-17-producing T cells in lupus. Curr Opin Rheumatol.
60. Shah K., Lee W.W., Lee S.H., Kim S.H., Kang S.W., Craft J., et al. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther 2010, 12(2):R53.
61. Crispin J.C., Oukka M., Bayliss G., Cohen R.A., Van Beek C.A., Stillman I.E., et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 2008, 181(12):8761-8766.
62. Stark M.A., Huo Y., Burcin T.L., Morris M.A., Olson T.S., Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005, 22(3):285-294.
63. Zhang Z., Kyttaris V.C., Tsokos G.C. The role of IL-23/IL-17 axis in lupus nephritis. J Immunol 2009, 183(5):3160-3169.
64. Matsumoto K., Kanmatsuse K. Interleukin-17 stimulates the release of pro-inflammatory cytokines by blood monocytes in patients with IgA nephropathy. Scand J Urol Nephrol 2003, 37(2):164-171.
65. Paust H.J., Turner J.E., Steinmetz O.M., Peters A., Heymann F., Holscher C., et al. The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol 2009, 20(5):969-979.
66. Gan PY, Steinmetz OM, Tan DS, O'Sullivan KM, Ooi JD, Iwakura Y, et al. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J Am Soc Nephrol.
67. Summers S.A., Steinmetz O.M., Li M., Kausman J.Y., Semple T., Edgtton K.L., et al. Th1 and Th17 cells induce proliferative glomerulonephritis. J Am Soc Nephrol 2009, 20(12):2518-2524.
68. Gan P.Y., Steinmetz O.M., Tan D.S., O'Sullivan K.M., Ooi J.D., Iwakura Y., et al. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J Am Soc Nephrol 2010, 21(6):925-931.
69. Charles E.D., Dustin L.B. Hepatitis C virus-induced cryoglobulinemia. Kidney Int 2009, 76(8):818-824.
70. Antonelli A., Ferri C., Ferrari S.M., Ghiri E., Goglia F., Pampana A., et al. Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia. Arthritis Rheum 2009, 60(12):3841-3847.
71. Cooper A.M., Khader S.A. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev 2008, 226:191-204.
72. Szekanecz Z., Koch A.E. Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res Ther 2008, 10(5):224.
73. Gourh P., Arnett F.C., Assassi S., Tan F.K., Huang M., Diekman L., et al. Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations. Arthritis Res Ther 2009, 11(5):R147.
74. Meloni F., Solari N., Cavagna L., Morosini M., Montecucco C.M., Fietta A.M. Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. Clin Exp Rheumatol 2009, 27(5):765-772.
75. Libby P., Pober J.S. Chronic rejection. Immunity 2001, 14(4):387-397.
76. Rahmani M., Cruz R.P., Granville D.J., McManus B.M. Allograft vasculopathy versus atherosclerosis. Circ Res 2006, 99(8):801-815.
77. Nickeleit V., Vamvakas E.C., Pascual M., Poletti B.J., Colvin R.B. The prognostic significance of specific arterial lesions in acute renal allograft rejection. J Am Soc Nephrol 1998, 9(7):1301-1308.
78. Hsieh H.G., Loong C.C., Lui W.Y., Chen A., Lin C.Y. IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl Int 2001, 14(5):287-298.
79. Tang J.L., Subbotin V.M., Antonysamy M.A., Troutt A.B., Rao A.S., Thomson A.W. Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation 2001, 72(2):348-350.
80. Itoh S., Nakae S., Axtell R.C., Velotta J.B., Kimura N., Kajiwara N., et al. IL-17 contributes to the development of chronic rejection in a murine heart transplant model. J Clin Immunol 2010, 30(2):235-240.
81. Faust S.M., Lu G., Marini B.L., Zou W., Gordon D., Iwakura Y., et al. Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J Immunol 2009, 183(11):7297-7306.
82. Antonysamy M.A., Fanslow W.C., Fu F., Li W., Qian S., Troutt A.B., et al. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 1999, 162(1):577-584.
83. Rao D.A., Eid R.E., Qin L., Yi T., Kirkiles-Smith N.C., Tellides G., et al. Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection. J Exp Med 2008, 205(13):3145-3158.
84. Cohen Tervaert J.W. Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis. Clin Exp Immunol 2009, 156(3):377-385.